Mml Investors Services, LLC Biogen Inc. Transaction History

Mml Investors Services, LLC

$27.4 Billion
Q3 2024

A detailed history of Mml Investors Services, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 10,280 shares of BIIB stock, worth $1.55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,280

Previous 9,900 3.84%

Holding current value

$1.55 Million

Previous $2.3 Million 13.16%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$189.07 - $236.8 $71,846 - $89,984	380 Added 3.84%	10,280 $1.99 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $11,050 - $13,729	58 Added 0.59%	9,900 $2.3 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $215,624 - $272,261	-1,017 Reduced 9.37%	9,842 $2.12 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $104,617 - $125,931	470 Added 4.52%	10,859 $2.81 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $142,607 - $160,956	-563 Reduced 5.14%	10,389 $2.67 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $1.13 Million - $1.31 Million	4,118 Added 60.26%	10,952 $3.12 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $277,597 - $316,311	-1,082 Reduced 13.67%	6,834 $1.9 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $275,412 - $334,631	1,091 Added 15.99%	7,916 $2.19 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $23,752 - $32,752	-122 Reduced 1.76%	6,825 $1.82 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $226,923 - $269,854	1,210 Added 21.09%	6,947 $1.42 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $1.27 Million - $1.61 Million	-6,576 Reduced 53.41%	5,737 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $157,863 - $202,877	-705 Reduced 5.42%	12,313 $2.95 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $721,058 - $940,339	2,548 Added 24.34%	13,018 $3.68 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $480,186 - $768,872	-1,854 Reduced 15.04%	10,470 $3.63 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $5,344 - $6,261	-22 Reduced 0.18%	12,324 $3.45 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $555,683 - $836,441	2,352 Added 23.53%	12,346 $3.02 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $244,647 - $282,476	924 Added 10.19%	9,994 $2.84 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $210,290 - $278,493	813 Added 9.85%	9,070 $2.43 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $245,728 - $311,710	-914 Reduced 9.97%	8,257 $2.61 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $195,193 - $269,710	887 Added 10.71%	9,171 $2.72 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $390,304 - $437,764	-1,795 Reduced 17.81%	8,284 $1.93 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $223,237 - $246,070	-1,018 Reduced 9.17%	10,079 $2.36 Million
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $738,330 - $1.15 Million	3,407 Added 44.3%	11,097 $2.62 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $293,539 - $371,798	1,054 Added 15.88%	7,690 $2.31 Million
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $1.06 Million - $1.39 Million	3,621 Added 120.1%	6,636 $2.35 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $89,874 - $107,111	-349 Reduced 10.37%	3,015 $875,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $61,130 - $86,458	-235 Reduced 6.53%	3,364 $921,000
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $53,837 - $60,301	-175 Reduced 4.64%	3,599 $1.15 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $1.06 Million - $1.24 Million	3,774	3,774 $1.18 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Account

Mml Investors Services, LLC Biogen Inc. Transaction History